Dushyanth Surakanti

Sparta Biomedical, Inc. has developed a breakthrough device called ORMI™ to treat knee osteoarthritis. The company is based in Madison, NJ. The device has been granted breakthrough device designation by the FDA. The company is committed to improving motion, reducing pain, and increasing the quality of life of patients with osteoarthritis. ORMI™ is different from other technologies that focus on cartilage regeneration approaches, which can take a long time to grow and not be as strong as the original. The company was founded by Dushyanth Surakanti and Dimitrios Angelis, and Dushyanth Surakanti has been the CEO since incorporation.

Sparta Biopharma, Inc. develops and markets novel osteobiologics that possess both mineralize and demineralize layers intended to support healing and repair within the rotator cuff. The private company is based in Madison, NJ. The company was founded in 2018 by Dushyanth Surakanti, Dimitrios Angelis. Dushyanth Surakanti has been the CEO since 2018.

Sparta Biomedical, Inc. has developed a breakthrough device called ORMI™ to treat knee osteoarthritis. The company is based in Madison, NJ. The device has been granted breakthrough device designation by the FDA. The company is committed to improving motion, reducing pain, and increasing the quality of life of patients with osteoarthritis. ORMI™ is different from other technologies that focus on cartilage regeneration approaches, which can take a long time to grow and not be as strong as the original. The company was founded by Dushyanth Surakanti and Dimitrios Angelis, and Dushyanth Surakanti has been the CEO since incorporation.

Sparta Biopharma, Inc. develops and markets novel osteobiologics that possess both mineralize and demineralize layers intended to support healing and repair within the rotator cuff. The private company is based in Madison, NJ. The company was founded in 2018 by Dushyanth Surakanti, Dimitrios Angelis. Dushyanth Surakanti has been the CEO since 2018.

Sparta Biomedical, Inc. has developed a breakthrough device called ORMI™ to treat knee osteoarthritis. The company is based in Madison, NJ. The device has been granted breakthrough device designation by the FDA. The company is committed to improving motion, reducing pain, and increasing the quality of life of patients with osteoarthritis. ORMI™ is different from other technologies that focus on cartilage regeneration approaches, which can take a long time to grow and not be as strong as the original. The company was founded by Dushyanth Surakanti and Dimitrios Angelis, and Dushyanth Surakanti has been the CEO since incorporation.